These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36861797)

  • 1. Sugammadex
    Chhabra R; Gupta R; Gupta LK
    Curr Drug Saf; 2024; 19(1):33-43. PubMed ID: 36861797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults.
    Hristovska AM; Duch P; Allingstrup M; Afshari A
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012763. PubMed ID: 28806470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials.
    Carron M; Zarantonello F; Tellaroli P; Ori C
    J Clin Anesth; 2016 Dec; 35():1-12. PubMed ID: 27871504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sugammadex for the reversal of muscle relaxation in general anaesthesia: a systematic review and economic assessment.
    Chambers D; Paulden M; Paton F; Heirs M; Duffy S; Craig D; Hunter J; Wilson J; Sculpher M; Woolacott N
    Health Technol Assess; 2010 Jul; 14(39):1-211. PubMed ID: 20688009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: A pooled analysis of 26 studies.
    Herring WJ; Woo T; Assaid CA; Lupinacci RJ; Lemmens HJ; Blobner M; Khuenl-Brady KS
    J Clin Anesth; 2017 Sep; 41():84-91. PubMed ID: 28802619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sugammadex versus neostigmine for routine reversal of rocuronium block in adult patients: A cost analysis.
    Hurford WE; Welge JA; Eckman MH
    J Clin Anesth; 2020 Dec; 67():110027. PubMed ID: 32980763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of sugammadex for neuromuscular blockade reversal in pediatric patients: an updated meta-analysis of randomized controlled trials with trial sequential analysis.
    Lang B; Han L; Zeng L; Zhang Q; Chen S; Huang L; Jia Z; Yu Q; Zhang L
    BMC Pediatr; 2022 May; 22(1):295. PubMed ID: 35590273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective Analysis of the Safety and Efficacy of Sugammadex Versus Neostigmine for the Reversal of Neuromuscular Blockade in Children.
    Gaver RS; Brenn BR; Gartley A; Donahue BS
    Anesth Analg; 2019 Oct; 129(4):1124-1129. PubMed ID: 31584918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Clinical and Budgetary Impact Analysis of Introducing Sugammadex for Routine Reversal of Neuromuscular Blockade in a Hypothetical Cohort in the US.
    Jiang Y; Bash LD; Saager L
    Adv Ther; 2021 May; 38(5):2689-2708. PubMed ID: 33871823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recovery of muscle function after deep neuromuscular block by means of diaphragm ultrasonography and adductor of pollicis acceleromyography with comparison of neostigmine vs. sugammadex as reversal drugs: study protocol for a randomized controlled trial.
    Cappellini I; Picciafuochi F; Ostento D; Danti G; De Gaudio AR; Adembri C
    Trials; 2018 Feb; 19(1):135. PubMed ID: 29467022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of sugammadex and neostigmine for reversal of rocuronium-induced neuromuscular blockade in children.
    Ammar AS; Mahmoud KM; Kasemy ZA
    Acta Anaesthesiol Scand; 2017 Apr; 61(4):374-380. PubMed ID: 28185260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The comparative efficacy and safety of sugammadex and neostigmine in reversing neuromuscular blockade in adults. A Cochrane systematic review with meta-analysis and trial sequential analysis.
    Hristovska AM; Duch P; Allingstrup M; Afshari A
    Anaesthesia; 2018 May; 73(5):631-641. PubMed ID: 29280475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sugammadex for reversal of neuromuscular blockade in pediatric patients: Results from a phase IV randomized study.
    Voss T; Wang A; DeAngelis M; Speek M; Saldien V; Hammer GB; Wrishko R; Herring WJ
    Paediatr Anaesth; 2022 Mar; 32(3):436-445. PubMed ID: 34878707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory muscle activity after spontaneous, neostigmine- or sugammadex-enhanced recovery of neuromuscular blockade: a double blind prospective randomized controlled trial.
    Schepens T; Janssens K; Maes S; Wildemeersch D; Vellinga J; Jorens PG; Saldien V
    BMC Anesthesiol; 2019 Oct; 19(1):187. PubMed ID: 31629404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sugammadex Versus Neostigmine for Reversal of Neuromuscular Blockade in Patients With Severe Renal Impairment: A Randomized, Double-Blinded Study.
    Oh MW; Mohapatra SG; Pak T; Hermawan A; Chen CA; Thota B; Chen J; Siu E; Park J; Moon TS
    Anesth Analg; 2024 May; 138(5):1043-1051. PubMed ID: 38190344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O; White PF; Tufanogullari B; Klein K
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromuscular Blockade and Reversal Agent Practice Variability in the US Inpatient Surgical Settings.
    Bash LD; Turzhitsky V; Black W; Urman RD
    Adv Ther; 2021 Sep; 38(9):4736-4755. PubMed ID: 34319550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of sugammadex in accelerating postoperative discharge: A meta-analysis.
    Carron M; Zarantonello F; Lazzarotto N; Tellaroli P; Ori C
    J Clin Anesth; 2017 Jun; 39():38-44. PubMed ID: 28494905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects on Postoperative Gastrointestinal Motility After Neuromuscular Blockade Reversal With Sugammadex Versus Neostigmine/Glycopyrrolate in Colorectal Surgery Patients.
    Hunt ME; Yates JR; Vega H; Heidel RE; Buehler JM
    Ann Pharmacother; 2020 Dec; 54(12):1165-1174. PubMed ID: 32468846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Half-Dose Sugammadex After Neostigmine Versus Neostigmine as a Routine Reversal Agent: A Pilot Randomized Trial.
    Baysal A; Sagıroglu G; Dogukan M; Ozkaynak I
    J Perianesth Nurs; 2022 Jun; 37(3):326-332. PubMed ID: 35153119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.